{
    "title": "U.S. infectious disease group backs Gilead's remdesivir for COVID-19 treatment",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8978507/U-S-infectious-disease-group-backs-Gileads-remdesivir-COVID-19-treatment.html",
    "date": "2020-11-23",
    "keywords": [
        "use",
        "covid19",
        "drug",
        "idsa",
        "panel",
        "rebecca",
        "remdesivir",
        "recommendation",
        "trial",
        "benefit",
        "dr",
        "gandhi",
        "treatment",
        "association",
        "monday",
        "world",
        "health",
        "organization",
        "week",
        "society",
        "america",
        "need",
        "breathing",
        "assistance",
        "effect",
        "time",
        "recovery",
        "rajesh",
        "cochair",
        "management",
        "call",
        "survival",
        "approval",
        "whos",
        "study",
        "placebo",
        "comparison",
        "control",
        "group",
        "antibody",
        "bamlanivimab",
        "emergency",
        "authorization",
        "discussion",
        "doctor",
        "role",
        "data",
        "eye",
        "roche",
        "actemra",
        "tocilizumab",
        "evidence",
        "reporting",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}